Research Article

Secreted Frizzled-Related Protein 2 and Extracellular Volume Fraction in Patients with Heart Failure

Table 4

Prognostic value of clinical variables in Cox regression models.

VariablesUnivariateMultivariate
HR (95% CI) valueHR (95% CI) value

Age (each 10 years)1.59 (1.19, 2.12)0.0011.13 (1.04, 1.22)0.002
Sex (female vs. male)1.16 (0.36, 3.76)0.80
BMI (each 1 kg/m2)1.09 (0.97, 1.64)0.27
Diabetes (yes vs. no)1.26 (0.97, 1.64)0.081.09 (0.90, 1.32)0.38
Smoking (yes vs. no)1.42 (0.39, 5.14)0.59
SBP (each 10 mmHg)1.00 (0.98, 1.03)0.85
NT-proBNP (each doubling)3.46 (1.39, 8.61)0.0082.46 (1.05, 5.76)0.04
hs-CRP (each doubling)0.52 (0.23, 1.20)0.13
Sfrp2 (each doubling)1.25 (0.97, 1.64)0.091.18 (0.75, 1.86)0.47
ECV fraction (each doubling)1.79 (1.10, 2.91)0.021.68 (1.03, 2.74)0.04
LVEF (each doubling)0.49 (0.18, 1.33)0.16
eGFR (each doubling)0.42 (0.07, 2.42)0.33

BMI: body mass index; CI: confidence interval; ECV: extracellular volume; eGFR: estimated glomerular filtration rate; HR: hazard ratio; LVEF: left ventricular ejection fraction; SBP: systolic blood pressure; hs-CRP: high-sensitivity C-reactive protein; NT-proBNP: N-terminal pro-B-type natriuretic peptide; SFRP2: secreted frizzled-related protein 2.